SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-059963
Filing Date
2024-05-10
Accepted
2024-05-10 16:45:46
Documents
13
Period of Report
2024-05-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414135d1_8k.htm   iXBRL 8-K 29777
  Complete submission text file 0001104659-24-059963.txt   207240

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20240507.xsd EX-101.SCH 3054
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20240507_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20240507_pre.xml EX-101.PRE 22385
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2414135d1_8k_htm.xml XML 3795
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40363 | Film No.: 24935682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)